AngioDynamics to launch new varicose vein therapy brand
According to the company, the new brand will encompass the best of AngioDynamics’s VenaCure product line as well as EVLT, a product line which the company recently rescued
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.
The new labeling also provides information showing that Ranexa reduced arrhythmias including ventricular arrhythmias, new onset atrial fibrillation and a potentially dangerous slow heartbeat known as bradycardia in